// App-Quantinova.ai

: TMEM16 Antagonists Inhibit Phosphatidylserine-Induced Procoagulant Activity in Endothelial Cells and Protect From Thrombosis in vivo

Researchers

Presenter

  • Alec A Schmaier

Principal Investigators

  • Papa Freduah F Anderson

  • Siyu F Chen

  • Samir M Parikh

  • Robert C Flaumenhaft

  • Sol Schulman

Medical Centers

  • Cardiology, Beth Israel Deaconess Med Cntr, Harvard Med Sch, Boston, MA

  • Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Autoimmune (AI)

Disease

  • Venous thrombosis

  • Gout

Biomarkers

  • N/A

Drug/Treatment

  • Phosphatidylserine

  • Benzbromarone

  • Evithrom

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved